Abnormal intracellular distribution of NFAT1 in T lymphocytes from patients with systemic lupus erythematosus and characteristic clinical features

Clinical Immunology

Volumn 119, Issue 3, 2006, Pages 297-306

  Fujii, Yuko ^a   Fujii, Koichi ^a   Iwata, Shigeru ^a   Suzuki, Katsunori ^a   Azuma, Taeko ^a   Saito, Kazuyoshi ^a   Tanaka, Yoshiya ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Ca2+; Calcineurin; NFAT1; Systemic lupus erythematosus; T lymphocyte; TCR signaling

Indexed keywords

CALCINEURIN; CALCIUM ION; CYCLOSPORIN A; TRANSCRIPTION FACTOR NFAT;

ADULT; AGED; ARTICLE; CALCIUM SIGNALING; CELL FRACTIONATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IN VITRO STUDY; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PLEURISY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; CYCLOSPORINE; FEMALE; HUMANS; I-KAPPA B PROTEINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; NFATC TRANSCRIPTION FACTORS; T-LYMPHOCYTES;

EID: 33646412860     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.01.001     Document Type: Article

References (45)

1. Mok C.C., and Lau C.S. Pathogenesis of systemic lupus erythematosus. J. Clin. Pathol. 56 (2003) 481-490
2. Akahoshi M., Nashima H., Tanaka Y., Kohsaka T., Nagano S., Ohgami E., Arinobu Y., et al. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum. 42 (1999) 1644-1648
3. Linker-Israeli M., Bakke A.C., Kitridou R.C., Gendler S., Gillis S., and Horwitz D.A. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus. J. Immunol. 130 (1983) 2651-2655
4. Kammer G.M., Perl A., Richardson B.C., and Tsokos G.C. Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum. 46 (2002) 1139-1154
5. Kyttaris V.C., and Tsokos G.C. T lymphocytes in systemic lupus erythematosus: an update. Curr. Opin. Rheumatol. 16 (2004) 548-552
6. Liossis S.N.C., Ding X.Z., Dennis G.J., and Tsokos G.C. Altered pattern of TCR/CD3-mediated protein-tyrosyl phosphorylation in T cells from patients with systemic lupus erythematosus: deficient expression of the T cell receptor zeta chain. J. Clin. Invest. 101 (1998) 1448-1457
7. Brundula V., Rivas L.J., Blasini A.M., et al. Diminished levels of T cell receptor zeta chains in peripheral blood T lymphocytes from patients with systemic lupus erythematosus. Arthritis Rheum. 42 (1999) 1908-1916
8. Tada Y., Nagasawa K., Yamauchi Y., Tsukamoto H., and Niho Y. A defect in the protein kinase C system in T cells from patients with systemic lupus erythematosus. Clin. Immunol. Immunopathol. 60 (1991) 220-231
9. Kammer G.M., Khan I.U., and Malemud C.J. Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes. J. Clin. Invest. 94 (1994) 422-430
10. Kammer G.M. High prevalence of T cell type I protein kinase A deficiency in systemic lupus erythematosus. Arthritis Rheum. 42 (1999) 1458-1465
11. Mishra N., Khan I.U., Tsokos G.C., and Kammer G.M. Association of deficient type II protein kinase A activity with aberrant nuclear translocation of the RIIβ subunit in systemic lupus erythematosus T lymphocytes. J. Immunol. 165 (2000) 2830-2840
12. Solomou E.E., Juang Y.-T., Gourley M.F., Kammer G.M., and Tsokos G.C. Molecular basis of deficient IL-2 production in T cells from patients with systemic lupus erythematosus. J. Immunol. 166 (2001) 4216-4222
13. Wong H.K., Kammer G.M., Dennis G., and Tsokos G.C. Abnormal NF-kB activity in T lymphocytes from patients with systemic lupus erythematosus is associated with decreased p65-RelA protein expression. J. Immunol. 163 (1999) 1682-1689
14. Luo C., Burgeon E., and Rao A. Mechanisms of transactivation by nuclear factor of activated T cells-1. J. Exp. Med. 184 (1996) 141-147
15. Rao A., Luo C., and Hogan P.G. Transcription factors of NFAT family: regulation and function. Annu. Rev. Immunol. 15 (1997) 707-747
16. Hogan P.G., Chen L., Nardone J., and Rao A. Transcriptional regulation by calcium, calcineulin and NFAT. Genes Dev. 17 (2003) 2205-2232
17. Rooney J.W., Sun Y.L., Glimcher L.H., and Hoey T. Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol. Cell. Biol. 15 (1995) 6299-6310
18. Monticelli S., and Rao A. NFAT1 and NFAT2 are positive regulators of IL-4 gene transcription. Eur. J. Immunol. 32 (2002) 2971-2978
19. McCaffery P.G., Goldfeld A.E., and Rao A. The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-alpha gene transcription. J. Biol. Chem. 269 (1994) 30445-30450
20. Xanthoudakis S., Viola J., Shaw K., Luo C., Wallace J., Bozza P., Curran T., and Rao A. An enhanced immune response in mice lacking the transcription factor NFAT1. Science 272 (1996) 892-895
21. Luo C., Burgeon E., Carew J.A., McCaffrey P.G., Badalian T.M., and Lane W.S. Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes. Mol. Cell. Biol. 16 (1996) 3955-3966
22. Lyakh L., Ghosh P., and Rice N.R. Expression of NFAT- family proteins in normal human T cells. Mol. Cell. Biol. 17 (1997) 2475-2484
23. Shaw K.T.Y., Ho A.M., Raghavan J.K., Jain J., Park J., Sharma S., Rao A., and Hogan P.G. Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 11205-11209
24. Feske S., Draeger R., Peter H.H., Eichmann K., and Rao A. The duration of nuclear residence of NFAT determines the pattern of cytokine expression in human SCID T cells. J. Immunol. 165 (2000) 297-305
25. Becker H., Stengl G., Stein M., and Federlin III K. Analysis of proteins that interact with the IL-2 regulatory region in patients with rheumatic diseases. Clin. Exp. Immunol. 99 (1995) 325-350
26. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., Schaller J.G., Talal N., and Winchester R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25 (1982) 1271-1277
27. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H., and the Committee on Prognosis Studies in SLE. Derivation of SLEDAI: a disease activity index for lupus patients. Arthritis Rheum. 35 (1992) 630-640
28. Armitage P., Berry G., and Matthews J.N.S. Statistical Methods in Medical Research. 3rd ed. (2001), Blackwell Publishing
29. 2+/Calmodulin dependent protein kinase cascades in transcriptional regulation. J. Biol. Chem. 276 (2001) 2975-2978
30. Means A.R. Regulatory cascades involving calmodulin-dependent protein kinases. Mol. Endocrinol. 14 (2000) 4-13
31. Okamura H., Gaicia-Rodriguez C., Martinson H., Qin J., Virshop D.M., and Rao A. A conserved docking motif for CK1 binding controls the nuclear translocation of NFAT1. Mol. Cell. Biol. 24 (2004) 4184-4195
32. Liu J., Farmer J.J., Lane W.S., Friedman J., Weissman I., and Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66 (1991) 807-815
33. McCaffery P.G., Luo C., Kerppola T.K., Jain J., Badalian T.M., Ho A.M., Burgeon E., Lane W.S., Lambert J.N., Curran T., et al. Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science 262 (1993) 750-754
34. Handschumacher R.E., Harding M.W., Rice J., Drugge R.J., and Speicher D.W. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 226 (1984) 544-547
35. Beals C.R., Sheridan C.M., Turck C.W., Gardner P., and Crabtree G.R. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275 (1997) 1930-1933
36. Macian F. NFAT proteins: key regulators of T-cell development and function. Nat. Rev., Immunol. 5 (2005) 472-484
37. Juang Y.T., Wang Y., Solomou E.E., Li Y., Mawrin C., Tenbrock K., Kyttaris V.C., and Tsokos G.C. Systemic lupus erythematosus serum IgG increase CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. J. Clin. Invest. 115 (2005) 996-1005
38. Powell J.D., Lerner C.G., Ewoldt G.R., and Schwartz R.H. The -180 site for the IL-2 promoter is the target of CREB/CREM binding in T cell anergy. J. Immunol. 163 (1999) 6631-6639
39. Kammer G.M. Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm. J. Clin. Invest. 115 (2005) 836-840
40. Herrera-Esparza R., Barbosa-Cisneros O., Villalobos-Hurtado R., and Avalos-Diaz E. Renal expression of IL-6 and TNF alpha genes in lupus nephritis. Lupus 7 (1998) 154-158
41. Hass C., Ryffel B., and Hir M.L. IFN-γ receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZBxNZW) F1 mice. J. Immunol. 160 (1998) 3713-3718
42. Aringer M., and Smolen J.S. Cytokine expression in lupus kidneys. Lupus 14 (2005) 13-18
43. Uhm W.S., Na K., Song G.W., Jung S.S., Lee T., Park M.H., and Yoo D.H. Cytokine balance in kidney from lupus nephritis patients. Rheumatology 42 (2003) 935-938
44. Waldman M., and Madaio M.P. Pathogenic autoantibodies in lupus nephritis. Lupus 14 (2005) 19-24
45. Takada K., Illei G.G., and Boumpas D.T. Cyclophosphamide for the treatment of systemic lupus erythematosus. Lupus 10 (2001) 154-161